person · Reporting owner
NEUGENT CHRISTOPHER J
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Post Holdings, Inc.POST · Entity 692 | PRES & CEO-POST CONSUMER BRNDS | November 16, 2017 | November 17, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Post Holdings, Inc.
Report date November 16, 2017 · Filed November 17, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 38,203 |
Reported balance
After 2017-11-16 transaction · row 1
1 source rowRow 1 · 2017-11-16 · Tax withholding · Disposed 1,401 · Balance 38,203 F1: Surrender of shares in payment of tax withholding due as a result of the vesting of 4,167 RSUs in accordance with Rule 16b-3. |
Filing footnotes · ownership attribution and instrument terms
F1: Surrender of shares in payment of tax withholding due as a result of the vesting of 4,167 RSUs in accordance with Rule 16b-3.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Cibus, Inc.
Report date March 01, 2023 · Filed June 01, 2023
Section 16 reporting ended · disclosed 2023-06-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right-to-Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.55 · Expires 2030-08-04 | Direct | 0 |
Reported balance
After 2023-03-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-03-01 · Disposition to issuer · Disposed 7,500 · Balance 0 F1: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. |
| Stock Option (Right-to-Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.55 · Expires 2030-08-04 | Direct | 7,500 |
Reported balance
After 2023-03-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-03-01 · Grant · Acquired 7,500 · Balance 7,500 F1: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. |
| Stock Option (Right-to-Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.22 · Expires 2031-05-27 | Direct | 0 |
Reported balance
After 2023-03-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-03-01 · Disposition to issuer · Disposed 14,408 · Balance 0 F1: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. |
| Stock Option (Right-to-Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.22 · Expires 2031-05-27 | Direct | 14,408 |
Reported balance
After 2023-03-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-03-01 · Grant · Acquired 14,408 · Balance 14,408 F1: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. |
| Stock Option (Right-to-Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.30 · Expires 2032-06-13 | Direct | 0 |
Reported balance
After 2023-03-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2023-03-01 · Disposition to issuer · Disposed 36,400 · Balance 0 F1: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. |
| Stock Option (Right-to-Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.30 · Expires 2032-06-13 | Direct | 36,400 |
Reported balance
After 2023-03-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2023-03-01 · Grant · Acquired 36,400 · Balance 36,400 F1: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2023 Filed Jun 1, 2023 19:11 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right-to-Buy) · Derivative | 36,400 | Not disclosed Strike: $0.30 | Not disclosed |
DisclosureSEC source: 0001615594-23-000036 · primary_doc.xml · derivative · entry 6 NEUGENT CHRISTOPHER J · CIK 0001657549 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,400 Underlying: Common Stock · 36,400 shares Expires 2032-06-13 F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 1, 2023 19:11 UTC | Cibus, Inc. CLXT · Entity 6658 | Disposition to issuerStock Option (Right-to-Buy) · Derivative | 36,400 | Not disclosed Strike: $0.30 | Not disclosed |
DisclosureSEC source: 0001615594-23-000036 · primary_doc.xml · derivative · entry 5 NEUGENT CHRISTOPHER J · CIK 0001657549 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,400 shares Expires 2032-06-13 F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 1, 2023 19:11 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right-to-Buy) · Derivative | 14,408 | Not disclosed Strike: $4.22 | Not disclosed |
DisclosureSEC source: 0001615594-23-000036 · primary_doc.xml · derivative · entry 4 NEUGENT CHRISTOPHER J · CIK 0001657549 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,408 Underlying: Common Stock · 14,408 shares Expires 2031-05-27 F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 1, 2023 19:11 UTC | Cibus, Inc. CLXT · Entity 6658 | Disposition to issuerStock Option (Right-to-Buy) · Derivative | 14,408 | Not disclosed Strike: $4.22 | Not disclosed |
DisclosureSEC source: 0001615594-23-000036 · primary_doc.xml · derivative · entry 3 NEUGENT CHRISTOPHER J · CIK 0001657549 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,408 shares Expires 2031-05-27 F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 1, 2023 19:11 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right-to-Buy) · Derivative | 7,500 | Not disclosed Strike: $4.55 | Not disclosed |
DisclosureSEC source: 0001615594-23-000036 · primary_doc.xml · derivative · entry 2 NEUGENT CHRISTOPHER J · CIK 0001657549 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2030-08-04 F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 1, 2023 19:11 UTC | Cibus, Inc. CLXT · Entity 6658 | Disposition to issuerStock Option (Right-to-Buy) · Derivative | 7,500 | Not disclosed Strike: $4.55 | Not disclosed |
DisclosureSEC source: 0001615594-23-000036 · primary_doc.xml · derivative · entry 1 NEUGENT CHRISTOPHER J · CIK 0001657549 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2030-08-04 F1 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F1 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 16:04 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right-to-Buy) · Derivative | 36,400 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001615594-22-000033 · primary_doc.xml · derivative · entry 3 NEUGENT CHRISTOPHER J · CIK 0001657549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,400 Underlying: Common Stock · 36,400 shares Expires 2032-06-13 F2 · derivative.exercise_date: Option vests in full on the first anniversary of the date of the grant. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 17:33 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right-to-Buy) · Derivative | 14,408 | $0.00 Strike: $4.22 | $0.00 |
DisclosureSEC source: 0001615594-21-000065 · primary_doc.xml · derivative · entry 3 NEUGENT CHRISTOPHER J · CIK 0001657549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,408 Underlying: Common Stock · 14,408 shares Expires 2031-05-27 F3 · derivative.exercise_date: The option vests in full on 5/27/2022. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 17:33 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantCommon Stock | 7,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-21-000065 · primary_doc.xml · nonDerivative · entry 1 NEUGENT CHRISTOPHER J · CIK 0001657549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,804 F1 · shares: The Restricted Stock Units vest in full on 5/27/2022. Read SEC document |
| May 12, 2021 Filed May 13, 2021 17:58 UTC | Cibus, Inc. CLXT · Entity 6658 | PurchaseCommon Stock | 15,000 | $3.95 | $59,290.50 |
DisclosureSEC source: 0001615594-21-000056 · primary_doc.xml · nonDerivative · entry 2 NEUGENT CHRISTOPHER J · CIK 0001657549 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 15,000 F1 · ownership.nature: By Christopher J. Neugent Revocable Trust of which the reporting person and his wife are trustees and the reporting person is the beneficiary. Read SEC document |
| March 12, 2021 Filed Mar 18, 2021 16:54 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantRestricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-21-000032 · primary_doc.xml · derivative · entry 2 NEUGENT CHRISTOPHER J · CIK 0001657549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Calyxt, Inc. common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on March 12, 2022. F2 · derivative.expiration_date: The restricted stock units vest in full on March 12, 2022. Read SEC document |
| March 12, 2021 Filed Apr 2, 2021 16:47 UTC Amendment | Cibus, Inc. CLXT · Entity 6658 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-21-000043 · primary_doc.xml · nonDerivative · entry 1 NEUGENT CHRISTOPHER J · CIK 0001657549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,940 F1 · shares: The Restricted Stock Units reported on this Form 4 vest fully on March 12, 2022. Read SEC document |
| August 04, 2020 Filed Aug 7, 2020 18:07 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right-to-Buy) · Derivative | 7,500 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001615594-20-000050 · primary_doc.xml · derivative · entry 2 NEUGENT CHRISTOPHER J · CIK 0001657549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2030-08-04 F1 · derivative.exercise_date: Option vests as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| May 06, 2019 Filed May 8, 2019 20:34 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $15.59 | $0.00 |
DisclosureSEC source: 0001127602-19-017804 · form4.xml · derivative · entry 1 NEUGENT CHRISTOPHER J · CIK 0001657549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2029-05-06 F1 · derivative.exercise_date: The stock option to purchase shares of Calyxt, Inc. common stock ("Stock Option") was granted on May 6, 2019 and vests 15% on May 6, 2020 and 15% on May 6, 2021, with the remainder vesting quarterly (commencing with the third fiscal quarter of 2021) in equal installments over 42 months. Read SEC document |
| October 08, 2018 Filed Oct 10, 2018 17:28 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right to Buy) · Derivative | 29,400 | $0.00 Strike: $14.24 | $0.00 |
DisclosureSEC source: 0001127602-18-029918 · form4.xml · derivative · entry 2 NEUGENT CHRISTOPHER J · CIK 0001657549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,400 Underlying: Common Stock · 29,400 shares Expires 2028-10-08 F2 · derivative.exercise_date: The Stock Option was granted on October 8, 2018 and vests 15% on October 8, 2019 and 15% on October 8, 2020, with the remainder vesting quarterly (commencing with the first fiscal quarter of 2021) in equal installments over 42 months. Read SEC document |
| October 08, 2018 Filed Oct 10, 2018 17:28 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantRestricted Stock Units | 19,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-029918 · form4.xml · nonDerivative · entry 1 NEUGENT CHRISTOPHER J · CIK 0001657549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,600 F1 · security: The award of restricted stock units with respect to Calyxt, Inc. common stock was granted on October 8, 2018 and vests 15% on October 8, 2019 and 15% on October 8, 2020, with the remainder vesting quarterly (commencing with the first fiscal quarter of 2021) in equal installments over 42 months. Read SEC document |
| November 16, 2017 Filed Nov 17, 2017 21:13 UTC | Post Holdings, Inc. POST · Entity 692 | Tax withholdingCommon Stock | 1,401 | $82.26 | $115,246.26 |
DisclosureSEC source: 0001530950-17-000230 · wf-form4_151095322434710.xml · nonDerivative · entry 1 NEUGENT CHRISTOPHER J · CIK 0001657549 · PRES & CEO-POST CONSUMER BRNDS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,203 F1 · shares: Surrender of shares in payment of tax withholding due as a result of the vesting of 4,167 RSUs in accordance with Rule 16b-3. Read SEC document |
| November 14, 2017 Filed Nov 15, 2017 22:09 UTC | Post Holdings, Inc. POST · Entity 692 | Tax withholdingCommon Stock | 896 | $79.94 | $71,626.24 |
DisclosureSEC source: 0001530950-17-000214 · wf-form4_151078378195687.xml · nonDerivative · entry 1 NEUGENT CHRISTOPHER J · CIK 0001657549 · PRES & CEO-POST CONSUMER BRNDS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,604 F1 · shares: Surrender of shares in payment of tax withholding due as a result of the vesting of 2,666 RSUs in accordance with Rule 16b-3. Read SEC document |
| November 13, 2017 Filed Nov 15, 2017 22:09 UTC | Post Holdings, Inc. POST · Entity 692 | GrantEmployee Stock Option (right to buy) · Derivative | 39,506 | $0.00 Strike: $80.15 | $0.00 |
DisclosureSEC source: 0001530950-17-000214 · wf-form4_151078378195687.xml · derivative · entry 3 NEUGENT CHRISTOPHER J · CIK 0001657549 · PRES & CEO-POST CONSUMER BRNDS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,506 Underlying: Common Stock · 39,506 shares Expires 2027-11-13 F4 · derivative.exercise_date: The option to purchase 39,506 shares of common stock was awarded under the Post Holdings, Inc. 2016 Long-Term Incentive Plan in a transaction exempt under Rule 16b-3 and vest in equal increments over three years. Read SEC document |
| November 13, 2017 Filed Nov 15, 2017 22:09 UTC | Post Holdings, Inc. POST · Entity 692 | GrantRestricted Stock Units · Derivative | 9,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001530950-17-000214 · wf-form4_151078378195687.xml · derivative · entry 2 NEUGENT CHRISTOPHER J · CIK 0001657549 · PRES & CEO-POST CONSUMER BRNDS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,218 Underlying: Common Stock · 9,218 shares Expires 2027-11-13 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Post Holdings, Inc. common stock or a cash payment equal to the fair market value of one share of common stock at the Company's discretion upon vesting. The restricted stock units were awarded on November 13, 2017 under the Post Holdings, Inc. 2016 Long-Term Incentive Plan in a transaction exempt under Rule 16b-1 and vest in equal increments over three years. F3 · derivative.exercise_date: One-third of the restricted stock units vest on each of the first, second, and third anniversaries of the date of grant. Read SEC document |
| November 14, 2016 Filed Nov 16, 2016 22:16 UTC | Post Holdings, Inc. POST · Entity 692 | GrantEmployee Stock Option (right to buy) · Derivative | 43,000 | $0.00 Strike: $71.32 | $0.00 |
DisclosureSEC source: 0001530950-16-000502 · wf-form4_147933455987902.xml · derivative · entry 2 NEUGENT CHRISTOPHER J · CIK 0001657549 · PRES & CEO-POST CONSUMER BRNDS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,000 Underlying: Common Stock · 43,000 shares Expires 2026-11-14 F2 · derivative.exercise_date: The option to purchase 43,000 shares of common stock was awarded under the Post Holdings, Inc. 2016 Long-Term Incentive Plan in a transaction exempt under Rule 16b-3 and vest in equal increments over three years. Read SEC document |
| November 14, 2016 Filed Nov 16, 2016 22:16 UTC | Post Holdings, Inc. POST · Entity 692 | GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001530950-16-000502 · wf-form4_147933455987902.xml · nonDerivative · entry 1 NEUGENT CHRISTOPHER J · CIK 0001657549 · PRES & CEO-POST CONSUMER BRNDS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,500 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of Post Holdings, Inc. common stock or a cash payment equal to the fair market value of one share of common stock at the Company's discretion upon vesting. The restricted stock units were awarded on November 14, 2016 under the Post Holdings, Inc. 2016 Long-Term Incentive Plan in a transaction exempt under Rule 16b-3 and vest in equal increments over three years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.